In a patient with non‑ST‑segment elevation myocardial infarction scheduled for coronary angiography within 24 hours, should a second antiplatelet agent be added?

Yes, a second antiplatelet agent should be administered to NSTEMI patients scheduled for coronary angiography within 24 hours.

For NSTEMI patients with planned coronary angiography within 24 hours, dual antiplatelet therapy (DAPT) should be initiated on presentation with aspirin plus a P2Y12 inhibitor (clopidogrel or ticagrelor) or a GP IIb/IIIa inhibitor before the procedure. 1, 2

Algorithmic Approach to Second Antiplatelet Selection

Step 1: Initiate Aspirin Immediately

• Administer aspirin as soon as possible after hospital presentation (Class I, Level A) 1
• Continue indefinitely unless contraindicated

Step 2: Choose Second Antiplatelet Based on Timing and Strategy

For Early Invasive Strategy (CAG within 24 hours):

You have three evidence-based options for the second antiplatelet agent:

Option A - P2Y12 Inhibitor (Preferred for most patients):

• Clopidogrel 600 mg loading dose (Level of Evidence: B) 1, 3
• Ticagrelor 180 mg loading dose (Level of Evidence: B) 1, 3
• Administer "as early as possible before or at the time of PCI" 1

Option B - IV GP IIb/IIIa Inhibitor:

• Eptifibatide or tirofiban (preferred agents) (Level of Evidence: A) 1
• Particularly reasonable in high-risk patients with elevated troponin, diabetes, or significant ST-segment depression 4

Option C - Delayed Administration:

• Wait until coronary anatomy is defined, then give prasugrel 60 mg at time of PCI (Level of Evidence: B) 1
• Do NOT use prasugrel if prior stroke/TIA (Class III: Harm) 1

Key Nuances and Evidence Considerations

The Pretreatment Controversy

The evidence shows conflicting data on upstream (pretreatment) versus at-time-of-PCI administration:

• Older guidelines (2002-2013) strongly recommended pretreatment based on CURE trial data showing benefit with clopidogrel 5, 1
• Most recent 2025 ACC/AHA guidelines acknowledge this controversy: "In patients with non–ST-segment elevation ACS who are scheduled for an invasive strategy with timing of angiography to be >24 hours, upstream treatment with clopidogrel or ticagrelor may be considered" 2
• Canadian 2024 guidelines suggest against routine pretreatment if CAG expected ≤24 hours (Weak Recommendation) 6

The Critical Distinction: Your Patient Has CAG Planned in 24 Hours

This timing matters significantly:

• If CAG is truly within 24 hours, the most recent high-quality evidence (2024 Canadian guidelines) suggests pretreatment may not be necessary 6
• However, the 2025 ACC/AHA guidelines still support dual antiplatelet therapy "on presentation" for medium-to-high risk patients with early invasive strategy 2
• Real-world consideration: If there's uncertainty about actually achieving CAG within 24 hours (common in many centers), pretreatment becomes more reasonable 7, 8

Practical Decision Algorithm

Give second antiplatelet on presentation if:

• High-risk features present (elevated troponin, hemodynamic instability, recurrent ischemia)
• Uncertainty exists about achieving 24-hour CAG timeline
• No high bleeding risk or need for urgent CABG

Consider waiting until anatomy known if:

• Low-risk patient (TIMI score <2)
• High bleeding risk
• Strong suspicion of anatomy requiring CABG
• Guaranteed CAG access within 2-4 hours 6, 8

Common Pitfalls to Avoid

1. Don't give prasugrel before knowing anatomy - increased bleeding without benefit, and contraindicated if CABG needed 1

2. Don't use abciximab - specifically contraindicated when PCI not planned (Class III) 4

3. Don't skip the second antiplatelet entirely - even if delaying to catheterization, DAPT is Class I recommendation for NSTEMI 1, 2

4. Don't forget to hold clopidogrel 5-7 days before CABG if anatomy shows need for surgery 1

5. Don't use maintenance aspirin >100 mg daily with ticagrelor - increased bleeding risk 1

Bleeding Risk Mitigation

For patients requiring DAPT who have bleeding concerns:

• Add proton pump inhibitor if GI bleeding risk 2
• Consider lower clopidogrel dose (300 mg load) if extreme bleeding risk, though 600 mg preferred 6
• Weight-based prasugrel dosing: 5 mg maintenance if <60 kg 1

The bottom line: For your NSTEMI patient with CAG planned in 24 hours, initiate aspirin immediately and add either clopidogrel 600 mg or ticagrelor 180 mg on presentation, unless specific contraindications exist or you have guaranteed catheterization access within 2-4 hours. 1, 2